Non-sterile, Powder Free Nitrile Examination Aloe Vera Green Gloves, Low Dermatitis Potential, Tested for use with Chemotherapy Drugs, Fentanyl Citrate and Simulated Gastric Acid;Non-sterile, Powder Free Nitrile Examination Gloves, Low Dermatitis Potential, Tested for use with Chemotherapy Drugs, Fentanyl Citrate and Simulated Gastric Acid Blue;Non-sterile, Powder Free Nitrile Examination Gloves - Pink
Yty Industry (Manjung) Sdn Bhd · Decision date Oct 1, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-10-01 for K262208, a traditional 510(k) submitted 06/30/2026 by Yty Industry (Manjung) Sdn Bhd of Sitiawan, Malaysia. The listed device is a polymer patient examination glove under regulation 880.6250, classified under product code LZA with subsequent codes LZC, OPJ and QDO, in the General Hospital specialty. SESE denotes clearance to market, not PMA approval.
The device name covers non-sterile, powder-free nitrile examination gloves in aloe vera green, blue and pink variants, described as low dermatitis potential and tested for use with chemotherapy drugs, fentanyl citrate and simulated gastric acid. The record does not identify a predicate device, summarize the comparison, or give test results, so the basis for equivalence and any performance data remain unknown. The page was last updated 10/26/2026.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General Hospital
- Decision date
- Oct 1, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262208
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Yty Industry (Manjung) Sdn Bhd
- Product code
- LZA
- Decision code
- SESE
- Decision date
- Oct 1, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Polymer Patient Examination Glove.
- Applicant
- Yty Industry (Manjung) Sdn Bhd
- Product code
- LZA
- FDA device class
- 1
FDA decision timeline
K262208 received
Application receipt date recorded by FDA.
K262208 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code LZA
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Vietglove Corporation | 510(k) clearance | Oct 29, 2026 | FDA | |
| Maxter Healthcare, Inc. | 510(k) clearance | Sep 9, 2026 | FDA | |
| Top Glove Sdn. Bhd. | 510(k) clearance | Sep 9, 2026 | FDA | |
| Gmp Medicare Sdn. Bhd. | 510(k) clearance | Sep 8, 2026 | FDA | |
| Cardinalhealth | 510(k) clearance | Sep 2, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Yty Industry (Manjung) Sdn Bhd
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Sitiawan
Sources and methodology
- Original FDA record: K262208
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
